Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04967976 · ClinicalTrials.gov registry record · NA
Breast Mesh Used in Two-staged Breast Reconstruction
A NA study of Breast Cancer and Breast Reconstruction, sponsored by Tianjin Medical University Cancer Institute and Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 6
- Study locations
NCT04967976 is a NA study of Breast Cancer and Breast Reconstruction that is actively recruiting participants, run by Tianjin Medical University Cancer Institute and Hospital. The registered enrollment target is 300 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (89% lower). The trial reports 6 study locations across 6 states.
The verdict
NCT04967976, a NA study of Breast Cancer and Breast Reconstruction, is actively recruiting participants, sponsored by Tianjin Medical University Cancer Institute and Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 6
- Study locations
Study Summary
This is the first prospective randomized and controlled study on the efficacy and safety of TiLOOP® Bra mesh in patients with expander-implant breast reconstruction. The investigators hypothesize that incoporating TiLOOP Bra mesh with tissue expanders will reduce the rates of capsular contraction, improve the efficiency of expansion and provide better aesthetic result.
Conditions Studied
Interventions
- PROCEDURE TiLoop Bra mesh in expander-implant breast reconstrution
- PROCEDURE sub-pectoral expander-implant breast reconstruction
Study Locations (6)
Texas
- MD Anderson Cancer Center - Houston
Gansu
- Gansu Provincial Cancer Hospital - Lanzhou
Jilin
- Jilin Cancer Hospital - Ch’ang-ch’un
Tianjin Municipality
- Tianjin Medical University Cancer Institute and Hospital - Tianjin
Zhejiang
- Zhejiang Provincial People's Hospital - Hangzhou
Other
- Technical University of Munich - Munich
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2021-08-01 |
| Est. Completion | 2026-08-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04967976
The ClinicalTrials.gov registry entry for NCT04967976 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (89% lower). The listed sponsor is Tianjin Medical University Cancer Institute and Hospital, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which TiLoop Bra mesh in expander-implant breast reconstrution is the first listed.
NCT04967976 reports 6 study locations spanning 6 distinct geographic areas - top geographies include Texas, Gansu, Jilin.
Frequently Asked Questions
What is clinical trial NCT04967976 about?
NCT04967976 is a clinical study titled "Breast Mesh Used in Two-staged Breast Reconstruction". This is the first prospective randomized and controlled study on the efficacy and safety of TiLOOP® Bra mesh in patients with expander-implant breast reconstruction. The investigators hypothesize that incoporating TiLOOP Bra mesh with tissue expanders will reduce the rates of capsular contraction, i...
What is the current status of trial NCT04967976?
This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2021-08-01. Estimated completion is 2026-08-01.
What conditions does trial NCT04967976 study?
This clinical trial studies the following conditions: Breast Cancer, Breast Reconstruction, Radiation, Synthetic Mesh.
What interventions are being tested in trial NCT04967976?
The interventions under investigation include: TiLoop Bra mesh in expander-implant breast reconstrution (PROCEDURE), sub-pectoral expander-implant breast reconstruction (PROCEDURE).
Who is sponsoring clinical trial NCT04967976?
This trial is sponsored by Tianjin Medical University Cancer Institute and Hospital, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04967976 being conducted?
This trial has 6 study locations across Texas, Gansu, Jilin, Tianjin Municipality, Zhejiang. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.